Trial Profile
Phase IV study evaluating safety of bevacizumab in patients with colorectal cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 08 Oct 2016 New trial record